£414K
The Greater Manchester spinout secured the capital from backers including The North West Fund for Biomedical and Central Manchester Foundation Trust to fund pre-clinical trials.
"Manchester is committed to its strategic and operational support for business growth and Co Angel Investment are just one of the services we have supported which is making a difference. We knew when we launched Co that Manchester held huge potential for a better, lower risk investment platform: the growing businesses like Gelexir are here, the Angels are here and now we have the infrastructure to bring them together to release further potential in the region."